Competition law concerns currently prevent tens of thousands of NHS patients from receiving combination therapies. This is because companies feel unable to adjust the prices of their component medicines which may result in accusations of illegal information exchange or price fixing. The CMA has set out five conditions for suppliers to lower their prices and make combination therapy cost-effective. However, the CMA admits this will not resolve all competition law barriers to combination therapies.
Chinese APT Group IT Service Provider Leveraging Microsoft Console Debugger to Exfiltrate Data
In early 2025, a novel campaign attributed to the Chinese APT group known as Jewelbug began targeting an IT service provider in Russia. The attackers
